+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Genentech, Inc.  - logo

Genentech, Inc., a biotechnology company, engages in the research, development, manufacture, and marketing of biotechnology products for treating patients with serious or life-threatening diseases in the United States. It offers molecular entities and medicines in the areas of oncology, immunology, neuroscience, metabolism, and infectious diseases. The company was founded in 1976 and is headquartered in South San Francisco, California. Genentech operates as a subsidiary of Roche Holdings, Inc.

Biomanufacturing Market - Global Strategic Business Report - Product Thumbnail Image

Biomanufacturing Market - Global Strategic Business Report

  • Report
  • December 2025
  • 375 Pages
  • Global
From
Hormone Therapy Market Report 2025 - Product Thumbnail Image

Hormone Therapy Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
From
From
From
From
Bronchiolitis Obliterans Syndrome - Pipeline Insight, 2025 - Product Thumbnail Image

Bronchiolitis Obliterans Syndrome - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
From
Parathyroid Hormone Market Report 2025 - Product Thumbnail Image

Parathyroid Hormone Market Report 2025

  • Report
  • April 2025
  • 250 Pages
  • Global
From
Pituitary Dwarf Treatment Market Report 2025 - Product Thumbnail Image

Pituitary Dwarf Treatment Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
GLP-1 Receptor Agonist Market Report 2025 - Product Thumbnail Image

GLP-1 Receptor Agonist Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
Multiple Sclerosis Drugs Market Analysis & Forecast to 2024-2034 - Product Thumbnail Image

Multiple Sclerosis Drugs Market Analysis & Forecast to 2024-2034

  • Report
  • January 2024
  • 200 Pages
  • Global
From
From
From
Neuroendocrine Tumors - Pipeline Insight, 2025 - Product Thumbnail Image

Neuroendocrine Tumors - Pipeline Insight, 2025

  • Clinical Trials
  • July 2025
  • 280 Pages
  • Global
From
From
Loading Indicator